(Q55033205)
Statements
Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. (English)
1 reference
Faraone SV
1 reference
Biederman J
1 reference
Wilens T
1 reference
Mick E
1 reference
Spencer T
1 reference
1 August 1999
1 reference
104
1 reference
2
1 reference
e20
1 reference